Bortezomib in Rejection of Kidney Transplants

Clinical trial NCT02201576 · COMPLETED

Trial details

NCT number: NCT02201576
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Antibody-mediated Transplant Rejection

Start date: 2015-02-11
Primary completion: 2020-07-16
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.